166 related articles for article (PubMed ID: 31996884)
1. Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide.
Zhang W; Taheri-Ledari R; Hajizadeh Z; Zolfaghari E; Ahghari MR; Maleki A; Hamblin MR; Tian Y
Nanoscale; 2020 Feb; 12(6):3855-3870. PubMed ID: 31996884
[TBL] [Abstract][Full Text] [Related]
2. Potent antibacterial nanoparticles for pathogenic bacteria.
Lai HZ; Chen WY; Wu CY; Chen YC
ACS Appl Mater Interfaces; 2015 Jan; 7(3):2046-54. PubMed ID: 25584802
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-modified Fe
Wang C; Zhang K; Zhou Z; Li Q; Shao L; Hao RZ; Xiao R; Wang S
Int J Nanomedicine; 2017; 12():3077-3094. PubMed ID: 28450783
[TBL] [Abstract][Full Text] [Related]
4. Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity.
Kaur A; Preet S; Kumar V; Kumar R; Kumar R
Colloids Surf B Biointerfaces; 2019 Apr; 176():62-69. PubMed ID: 30594704
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial therapeutic enhancement of levofloxacin via conjugation to a cell-penetrating peptide: An efficient sonochemical catalytic process.
Taheri-Ledari R; Maleki A
J Pept Sci; 2020 Oct; 26(10):e3277. PubMed ID: 32729203
[TBL] [Abstract][Full Text] [Related]
6. A therapeutic polyelectrolyte-vitamin C nanoparticulate system in polyvinyl alcohol-alginate hydrogel: An approach to treat skin and soft tissue infections caused by Staphylococcus aureus.
George L; Bavya MC; Rohan KV; Srivastava R
Colloids Surf B Biointerfaces; 2017 Dec; 160():315-324. PubMed ID: 28950196
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial Activity of Vancomycin Encapsulated in Poly(DL-lactide-co-glycolide) Nanoparticles Using Electrospraying.
Booysen E; Bezuidenhout M; van Staden ADP; Dimitrov D; Deane SM; Dicks LMT
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):310-316. PubMed ID: 29961212
[TBL] [Abstract][Full Text] [Related]
8. Bacteriolysis by vancomycin-conjugated acryl nanoparticles and morphological component analysis.
Shimizu N; Otsuka K; Sawada H; Maejima T; Shirotake S
Drug Dev Ind Pharm; 2014 Jun; 40(6):813-8. PubMed ID: 23594303
[TBL] [Abstract][Full Text] [Related]
9. pH-Responsive Lipid-Dendrimer Hybrid Nanoparticles: An Approach To Target and Eliminate Intracellular Pathogens.
Maji R; Omolo CA; Agrawal N; Maduray K; Hassan D; Mokhtar C; Mackhraj I; Govender T
Mol Pharm; 2019 Nov; 16(11):4594-4609. PubMed ID: 31593478
[TBL] [Abstract][Full Text] [Related]
10. In vitro antimicrobial effect of encapsulated vancomycin on internalized Staphylococcus aureus within endothelial cells.
Nettey H; Haswani D; D'Souza M; Oettinger C
Drug Dev Ind Pharm; 2007 Feb; 33(2):133-9. PubMed ID: 17454044
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-Loaded Fe
Taheri-Ledari R; Tarinsun N; Sadat Qazi F; Heidari L; Saeidirad M; Ganjali F; Ansari F; Hassanzadeh-Afruzi F; Maleki A
Inorg Chem; 2023 Feb; 62(6):2530-2547. PubMed ID: 36734619
[TBL] [Abstract][Full Text] [Related]
12. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
[TBL] [Abstract][Full Text] [Related]
13. Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin.
Ruczyński J; Rusiecka I; Turecka K; Kozłowska A; Alenowicz M; Gągało I; Kawiak A; Rekowski P; Waleron K; Kocić I
Sci Rep; 2019 Mar; 9(1):3247. PubMed ID: 30824786
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin-modified mesoporous silica nanoparticles for selective recognition and killing of pathogenic gram-positive bacteria over macrophage-like cells.
Qi G; Li L; Yu F; Wang H
ACS Appl Mater Interfaces; 2013 Nov; 5(21):10874-81. PubMed ID: 24131516
[TBL] [Abstract][Full Text] [Related]
15. Cell-Penetrating And Antibacterial BUF-II Nanobioconjugates: Enhanced Potency Via Immobilization On Polyetheramine-Modified Magnetite Nanoparticles.
Perez J; Cifuentes J; Cuellar M; Suarez-Arnedo A; Cruz JC; Muñoz-Camargo C
Int J Nanomedicine; 2019; 14():8483-8497. PubMed ID: 31695376
[TBL] [Abstract][Full Text] [Related]
16. In situ synthesis of magnetic CaraPVA IPN nanocomposite hydrogels and controlled drug release.
Mahdavinia GR; Etemadi H
Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():250-60. PubMed ID: 25491827
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis of antibiotic loaded polylactic acid nanoparticles and their antibacterial activity against Escherichia coli O157:H7 and methicillin-resistant Staphylococcus aureus].
Herrera MT; Artunduaga JJ; Ortiz CC; Torres RG
Biomedica; 2017 Jan; 37(1):11-21. PubMed ID: 28527243
[TBL] [Abstract][Full Text] [Related]
19. Vancomycin-Functionalized Porphyrinic Metal-Organic Framework PCN-224 with Enhanced Antibacterial Activity against Staphylococcus Aureus.
Chen LJ; Liu YY; Zhao X; Yan XP
Chem Asian J; 2021 Aug; 16(15):2022-2026. PubMed ID: 34096181
[TBL] [Abstract][Full Text] [Related]
20. Targeting bacterial biofilms using vancomycin and multivalent cell-penetrating peptide labeled quantum dots.
Kumar M; Pandey SK; Lalhall A; Sharma R; Sharma RK; Wangoo N
J Biomed Mater Res B Appl Biomater; 2023 Feb; 111(2):284-294. PubMed ID: 36056808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
